Bristol-Myers Squibb Company (BMY) · page 123 of 197
The slide uses a numbered list to structure the argument, focusing on product failure, sales underperformance, and generic competition risks.
Activist deck · problem_statement · diagnose_problem · balanced density
Slide locked Sign in to view
Slide schematic 5/5
callout 1/1 list 1/1 paragraph 1/1 source-note 1/1 title 1/1
Components 5
primary numbered paragraph source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1